Mollie Barnard, ScD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology

ScD, Harvard School of Public Health




Dr. Barnard earned her ScD in epidemiology from the Harvard T.H. Chan School of Public Health. The primary goal of her research is to use molecular epidemiology to inform ovarian cancer prevention and early detection strategies. Dr. Barnard was awarded a National Cancer Institute F99 Predoctoral to Postdoctoral Fellow Transition Award to study the role of inflammation and immunity in ovarian tumor development. For the K00 postdoctoral phase of this award, she is working with Dr. Doherty researching the genetic epidemiology of ovarian cancer histotypes. Dr. Barnard is collaborating with investigators from the Utah Population Database, the Utah Cancer Registry, and Intermountain Healthcare to study ovarian cancer high-risk pedigrees. She is developing studies to discover susceptibility variants for ovarian cancer histotypes and to describe the occurrence of other disease types in families at high risk of ovarian cancer.

Center Faculty Member
Boston University School of Medicine
Slone Epidemiology Center



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Barnard ME, Martheswaran T, Van Meter M, Buys SS, Curtin K, Doherty JA. Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study. Cancer Epidemiol Biomarkers Prev. 2022 Jul 01; 31(7):1313-1323. PMID: 35511751; PMCID: PMC9250611; DOI: 10.1158/1055-9965.EPI-21-1249;
     
  2. Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA. Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study. J Med Genet. 2022 May 09. PMID: 35534206
     
  3. Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, Terry P, Alberg AJ, Bandera EV, Funkhouser E, Wu AH, Pearce CL, Pike M, Setiawan VW, Haiman CA, Palmer JR, LeMarchand L, Wilkens LR, Berchuck A, Doherty JA, Modugno F, Ness R, Moysich K, Karlan BY, Whittemore AS, McGuire V, Sieh W, Lawrenson K, Gayther S, Sellers TA, Pharoah P, Schildkraut JM. Identification of novel epithelial ovarian cancer loci in women of African ancestry. Int J Cancer. 2020 06 01; 146(11):2987-2998.View Related Profiles. PMID: 31469419; PMCID: PMC7523187; DOI: 10.1002/ijc.32653;
     
  4. Barnard ME, Beeghly-Fadiel A, Milne GL, Akam EY, Chan AT, Eliassen AH, Rosner BA, Shu XO, Terry KL, Xiang YB, Zheng W, Tworoger SS. Urinary PGE-M Levels and Risk of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1845-1852. PMID: 31387969; PMCID: PMC6825569; DOI: 10.1158/1055-9965.EPI-19-0597;
     
  5. Simon TG, Barnard ME, Chan AT. Aspirin Use and the Risk of Cancer-In Reply. JAMA Oncol. 2019 06 01; 5(6):913. PMID: 31046070; DOI: 10.1001/jamaoncol.2019.0633;
     
  6. Barnard ME, Poole EM, Curhan GC, Eliassen AH, Rosner BA, Terry KL, Tworoger SS. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies. JAMA Oncol. 2018 12 01; 4(12):1675-1682. PMID: 30286239; PMCID: PMC6400245; DOI: 10.1001/jamaoncol.2018.4149;
     
  7. Barnard ME, Hecht JL, Rice MS, Gupta M, Harris HR, Eliassen AH, Rosner BA, Terry KL, Tworoger SS. Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1509-1517. PMID: 30377203; PMCID: PMC6415678; DOI: 10.1158/1055-9965.EPI-18-0346;
     
  8. Merritt MA, Rice MS, Barnard ME, Hankinson SE, Matulonis UA, Poole EM, Tworoger SS. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study. Lancet Oncol. 2018 08; 19(8):1107-1116. PMID: 30029888; PMCID: PMC6242286; DOI: 10.1016/S1470-2045(18)30373-5;
     
  9. Barnard ME, Pyden A, Rice MS, Linares M, Tworoger SS, Howitt BE, Meserve EE, Hecht JL. Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies. Gynecol Oncol. 2018 09; 150(3):521-526. PMID: 30001835; PMCID: PMC6102072; DOI: 10.1016/j.ygyno.2018.07.003;
     
  10. Birmann BM, Barnard ME, Bertrand KA, Bao Y, Crous-Bou M, Wolpin BM, De Vivo I, Tworoger SS. Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic. Am J Public Health. 2016 Sep; 106(9):1608-15.View Related Profiles. PMID: 27459458; PMCID: PMC4981809; DOI: 10.2105/AJPH.2016.303337;
     
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 7 distinct years, with a maximum of 4 publications in 2018

YearPublications
20111
20131
20152
20161
20184
20193
20222

2021 HCI, Salt Lake City, UT: Women’s Cancers Center Rising Star Award
2020 HCI, Salt Lake City, UT: Susan Cooper Jones Endowed Fellowship in Cancer Research
2020 HCI, Salt Lake City, UT: Huntsman Travel Fellowship
2019 University of Utah, Salt Lake City, UT: Postdoc Travel Assistance Award ($500 travel award)
2019 HCI, Salt Lake City, UT: Huntsman Travel Fellowship ($1,500 travel award)
2016 Harvard TH Chan School of Public Health: nominee for the National Cancer Institute (NCI) Predoctoral to Postdoctoral Fellow Transition Award
Contact for Mentoring:

72 E. Concord St
Boston MA 02118
Google Map


Barnard's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department